Richard Wang

Richard Wang is a Medical Industry Analyst with extensive experience in the pharmaceutical sector, currently working at 光大证券 since March 2018, focusing on biological medicine and innovative drugs. Richard’s previous roles include internships as a Medical Industry Analyst at China Asset Management Co., Ltd. and DongXing Securities Ltd., where research involved creating drug databases and analyzing the internationalization of pharmaceutical companies. Richard also conducted studies on the exportation of pharmaceuticals at China Galaxy Securities Co., LTD and began a career in marketing at Zhijianyi Culture Media Co., Ltd. Richard holds a Master of Science in chemicobiology and a Bachelor of Science in Pharmaceutical from Peking University.